STAT1 and breast carcinoma: Paralleling the results from the NKI dataset, patients from Vancouver with tumors displaying high STAT1 expression levels had a higher risk of death due to breast cancer (33% dead from breast cancer at 10 years) than patients with tumors showing low or absent STAT1 expression (25% dead at 10 years) (p = 0.056; Figure 8).